FDA Launches Major Review of CGMPs

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-10-02-2002, Volume 26, Issue 10

FDA is set to revise CGMPs to encourage new manufacturing technologies and develop improved agency policies to ensure drug quality and safety.

Related Content:

Regulatory/GMP ComplianceRegulatory WatchPharmaceutical Technology-10-02-2002
Drug Solutions Podcast: Point of Care and Patient Manufacturing
Mitigating Human Error and Supporting Compliance with Smart Technology
Quality Considerations for the Manufacture of Compounded Drugs